Adcytherix Website, Blog & Press Pages

Adcytherix Website, Blog & Press Pages - aVenture

Adcytherix - Library

adcytherix.comCrawled Oct 15, 2026

Blog

1 page

News/blog
ADCytherix's latest news. Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.

Press

4 pages

Adcytherix Doses First Patient in Phase 1 Trial of ADCX-020 and Strengthens Leadership to Support Next Phase of Growth/post/adcytherix-doses-first-patient-in-phase-1-trial-of-adcx-020-and-strengthens-leadership-to-support-ne
Initial patient dosed in the First-in-Human clinical trial of ADCX-020, marking Adcytherix’s transition into a clinical-stage company within its second year of operations.
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates/post/adcytherix-launches-with-30m-in-seed-funding-to-develop-next-generation-antibody-drug-conjugates
Adcytherix SAS announced its incorporation and €30 million in seed funding to develop antibody-drug conjugates for diseases such as cancer.
Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse/post/adcytherix-powers-ahead-technology-and-team-in-place-to-deliver-strategy-and-build-an-adc-powerhous
Adcytherix reinforces its Executive Committee with two pivotal appointments: CMO and CFO. The ADCX - Engine is operational to start driving execution.
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads/post/adcytherix-raises-eur-105m-series-a-to-accelerate-breakthrough-antibody-drug-conjugate-pipeline-with
The financing was led by Bpifrance, with co-leads Kurma Partners, Andera Partners, and Angelini Ventures, and will advance ADCX-020 toward the clinic; first IND and CTA filings are planned by the end of 2025.

Homepage

1 page

Homepage/
Adcytherix is a biopharmaceutical company developing antibody-drug conjugates to treat diseases such as cancer. It was founded by the former founders of Emergence Therapeutics.

Privacy

2 pages

Cookies policy/legal/cookies-policy
The website uses cookies and similar technologies to support its functioning, enhance user experience, and understand how visitors interact with its content.
Privacy Policy/legal/privacy-policy
The policy describes the collection, processing, and use of personal data.

Terms & Conditions

1 page

Legal Notice/legal/legal-notice
Adcytherix, a simplified joint-stock company (SAS)